Gojkovic, S., Krezic, I., Vranes, H., Zizek, H., Drmic, D., Vuletic, L
Weight Loss of Atlanta (Kennesaw) Services Explore the services provided at this location
Approved Uses and Potential New Benefits Currently, GLP-1 receptor agonists are approved for managing diabetes, obesity, and cardiovascular disease in overweight individuals
[1] [3] Whilst these mechanisms contribute to improved glycaemic control and weight reduction, they also account for one of the most commonly reported adverse effects: nausea
This is consistent with glucagon receptor activation, which has known cardiovascular effects
Since we do not know everything about your medical history and medications, please consult with your health care practitioner before implementing any new protocols and supplements